FI933719L - 4-((2-bensotiazolyl)metylamino)-a-((3,4-difluorfenoxi)metyl)-1-piperidinetanol - Google Patents

4-((2-bensotiazolyl)metylamino)-a-((3,4-difluorfenoxi)metyl)-1-piperidinetanol Download PDF

Info

Publication number
FI933719L
FI933719L FI933719A FI933719A FI933719L FI 933719 L FI933719 L FI 933719L FI 933719 A FI933719 A FI 933719A FI 933719 A FI933719 A FI 933719A FI 933719 L FI933719 L FI 933719L
Authority
FI
Finland
Prior art keywords
difluorphenoxi
piperidinetanol
benzothiazolyl
methylamino
methyl
Prior art date
Application number
FI933719A
Other languages
English (en)
Finnish (fi)
Other versions
FI933719A0 (fi
FI933719A7 (fi
Inventor
Raymond Antoine Stokbroekx
Gilbert Arthur Jules Grauwels
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI933719L publication Critical patent/FI933719L/fi
Publication of FI933719A0 publication Critical patent/FI933719A0/fi
Publication of FI933719A7 publication Critical patent/FI933719A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Paper (AREA)
FI933719A 1991-02-25 1992-02-14 4-((2-bentsotiatsolyyli)metyyliamino)-a-((3,4-difluorifenoksi)metyyli) -1-piperidiinietanoli FI933719A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65964591A 1991-02-25 1991-02-25
PCT/EP1992/000356 WO1992014731A1 (en) 1991-02-25 1992-02-14 4-[(2-BENZOTHIAZOLYL)METHYLAMINO]-α-[(3,4-DIFLUOROPHENOXY)METHYL]-1-PIPERIDINEETHANOL

Publications (3)

Publication Number Publication Date
FI933719L true FI933719L (fi) 1993-08-24
FI933719A0 FI933719A0 (fi) 1993-08-24
FI933719A7 FI933719A7 (fi) 1993-08-24

Family

ID=24646210

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933719A FI933719A7 (fi) 1991-02-25 1992-02-14 4-((2-bentsotiatsolyyli)metyyliamino)-a-((3,4-difluorifenoksi)metyyli) -1-piperidiinietanoli

Country Status (36)

Country Link
US (2) US5434168A (enExample)
EP (2) EP0501552A1 (enExample)
JP (1) JP2825652B2 (enExample)
KR (1) KR0165901B1 (enExample)
CN (3) CN1033454C (enExample)
AT (1) ATE131478T1 (enExample)
AU (1) AU649788B2 (enExample)
BG (1) BG62332B1 (enExample)
CA (1) CA2104000A1 (enExample)
CY (1) CY1924A (enExample)
CZ (1) CZ284705B6 (enExample)
DE (1) DE69206787T2 (enExample)
DK (1) DK0573473T3 (enExample)
DZ (1) DZ1560A1 (enExample)
EE (1) EE02983B1 (enExample)
ES (1) ES2083737T3 (enExample)
FI (1) FI933719A7 (enExample)
GR (1) GR3018692T3 (enExample)
HK (1) HK172296A (enExample)
HU (2) HUT67695A (enExample)
IE (1) IE69567B1 (enExample)
IL (3) IL113837A (enExample)
LV (1) LV11689B (enExample)
MA (1) MA22447A1 (enExample)
MX (1) MX9200777A (enExample)
NO (1) NO300591B1 (enExample)
NZ (2) NZ248437A (enExample)
PL (1) PL168791B1 (enExample)
RO (1) RO112959B1 (enExample)
RU (2) RU2094434C1 (enExample)
SK (1) SK278705B6 (enExample)
TN (1) TNSN92017A1 (enExample)
TW (1) TW218016B (enExample)
WO (1) WO1992014731A1 (enExample)
ZA (1) ZA921341B (enExample)
ZW (1) ZW1992A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol
TW282469B (enExample) * 1993-06-11 1996-08-01 Janssen Pharmaceutica Nv
CN1160348A (zh) * 1994-10-14 1997-09-24 詹森药业有限公司 口服沙贝鲁唑悬浮液
US5744484A (en) * 1994-11-24 1998-04-28 Janssen Pharmaceutica, N.V. Lubeluzole intravenous solutions
JPH10501823A (ja) * 1995-04-10 1998-02-17 バクスター、インターナショナル、インコーポレイテッド クモ膜下出血の治療における架橋ヘモグロビンの使用
AU7298296A (en) * 1995-10-25 1997-05-15 Janssen Pharmaceutica N.V. Lubeluzole n-oxide
US6025355A (en) 1997-05-19 2000-02-15 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
SK282769B6 (sk) * 1996-06-27 2002-12-03 Janssen Pharmaceutica N. V. N-[4-(Heteroarylmetyl)fenyl]heteroarylamín, spôsob jeho výroby a použitia, kompozícia na jeho báze
US6242198B1 (en) 1996-07-25 2001-06-05 Cambridge Neuroscience, Inc. Methods of treatment of eye trauma and disorders
US6756389B2 (en) 1996-08-09 2004-06-29 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
IL135176A0 (en) * 1997-11-10 2001-05-20 Bristol Myers Squibb Co Benzothiazole derivatives and pharmaceutical compositions containing the same
GB9815785D0 (en) * 1998-07-20 1998-09-16 Cerebrus Ltd Chemical compounds
JP2002544268A (ja) * 1999-05-12 2002-12-24 ニューロサーチ、アクティーゼルスカブ イオンチャネル調節剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3963732A (en) * 1973-05-30 1976-06-15 Tiberio Bruzzese Process for preparing dihydroxydiphenylmethane derivatives
GB1458392A (en) * 1973-11-09 1976-12-15 Ici Ltd Optically-active 1-aryloxy-2,3-epoxypropane derivatives
US4310658A (en) * 1980-06-18 1982-01-12 Allied Corporation Production of polyester thermally stabilized with an oxirane
CA1260474A (en) * 1984-12-03 1989-09-26 Raymond A. Stokbroekx Benzoxazol- and benzothiazolamine derivatives
US4861785A (en) * 1984-12-03 1989-08-29 Janssen Pharmaceutica N.V. Benzoxazol-and benzothiazolamine derivatives, useful as anti-anoxic agents
US4689330A (en) * 1985-04-15 1987-08-25 Janssen Pharmaceutica N.V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4749702A (en) * 1985-04-15 1988-06-07 Janssen Pharmaceutica N. V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
US4717760A (en) * 1986-07-10 1988-01-05 The Dow Chemical Company Fluorinated tris-epoxides based on triphenyl methane
JPH0643426B2 (ja) * 1986-07-25 1994-06-08 東京田辺製薬株式会社 イミダゾ〔４，５−ｂ〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol

Also Published As

Publication number Publication date
US5675027A (en) 1997-10-07
TNSN92017A1 (fr) 1993-06-08
DE69206787T2 (de) 1996-06-05
FI933719A0 (fi) 1993-08-24
WO1992014731A1 (en) 1992-09-03
ES2083737T3 (es) 1996-04-16
CS51292A3 (en) 1992-09-16
HU211560A9 (en) 1995-12-28
HUT67695A (en) 1995-04-28
HU9302395D0 (en) 1993-11-29
IL113837A (en) 1996-05-14
EE02983B1 (et) 1997-04-15
IL113837A0 (en) 1995-08-31
ZA921341B (en) 1993-08-24
US5434168A (en) 1995-07-18
CA2104000A1 (en) 1992-08-26
LV11689B (en) 1997-08-20
CN1064865A (zh) 1992-09-30
DE69206787D1 (de) 1996-01-25
NO300591B1 (no) 1997-06-23
ZW1992A1 (en) 1993-09-22
CN1033454C (zh) 1996-12-04
NO933010D0 (no) 1993-08-24
RO112959B1 (ro) 1998-02-27
MX9200777A (es) 1992-08-01
AU649788B2 (en) 1994-06-02
SK278705B6 (sk) 1998-01-14
EP0501552A1 (en) 1992-09-02
CN1117048A (zh) 1996-02-21
IL100952A (en) 1995-12-31
EP0573473B1 (en) 1995-12-13
IL100952A0 (en) 1992-11-15
EP0573473A1 (en) 1993-12-15
KR0165901B1 (en) 1999-01-15
CY1924A (en) 1997-03-07
PL168791B1 (pl) 1996-04-30
NZ241592A (en) 1994-07-26
DK0573473T3 (da) 1996-01-29
JP2825652B2 (ja) 1998-11-18
RU2094434C1 (ru) 1997-10-27
FI933719A7 (fi) 1993-08-24
IE920575A1 (en) 1992-08-26
RU2106348C1 (ru) 1998-03-10
GR3018692T3 (en) 1996-04-30
LV11689A (lv) 1997-02-20
HK172296A (en) 1996-09-20
NZ248437A (en) 1994-07-26
CN1113437A (zh) 1995-12-20
NO933010L (no) 1993-08-24
AU1208592A (en) 1992-09-15
TW218016B (enExample) 1993-12-21
JPH06505012A (ja) 1994-06-09
BG98068A (bg) 1994-06-30
CN1043609C (zh) 1999-06-16
IE69567B1 (en) 1996-10-02
RU95112519A (ru) 1997-04-20
ATE131478T1 (de) 1995-12-15
DZ1560A1 (fr) 2002-02-17
MA22447A1 (fr) 1992-10-01
BG62332B1 (bg) 1999-08-31
CZ284705B6 (cs) 1999-02-17

Similar Documents

Publication Publication Date Title
NO920018L (no) 1,3-oksatiolannukleosidanaloger
BR9106540A (pt) 1,4-diamino-2,3-didroxibutanos
BR9107141A (pt) N-((1,3,5-triazin-2-il)aminocarbonil)benzenossulfonamidas herbicidas
FI954979A7 (fi) Kemoherkistävinä aineina käytettävät 10,11-metanodibentsosuberaanijohdannaiset
FI923314L (fi) Substituerade cyklopropylamino-1,3,5-triaziner
FI931707L (fi) 1,2,4-oxadiazolyl-fenoxialkylisoxazoler och deras anvaendning som virusmotarbetande aemnen
AT397656B (de) (6,7-substituierte-8-alkoxy-1-cyclopropyl-1,4-
FI922875L (fi) Foereningar med reninhaemmande egenskaper, foerfarande foer deras framstaellning och deras anvaendning
FI933719L (fi) 4-((2-bensotiazolyl)metylamino)-a-((3,4-difluorfenoxi)metyl)-1-piperidinetanol
FI923774A7 (fi) 1,7-anellerade 2-(piperazinoalkyl)indolderivat samt foerfaranden och mellanprodukter foer deras framstaellning
FI922592L (fi) (arylalkylpiperidin-4-yl)metyl)-2a,3,4,5-tetra-hydro-1(2h)-acetnaftylen-1-oner och motsvarande foereningar, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
FI920435A7 (fi) N-(aryloxyalkyl) heteroaryl-8 -azabicyclo/3.2.1./oktaner, mellanprodukter och deras framstaellnings -foerfarande och deras anvaendning som laekemedel.
FI920192L (fi) Substituerade 1,2,3,4-tetrahydro -cyklopent/b/indoler, 1,2,3,3a,4,8a-hexahydrocyklopent/b/indoler och motsvarande foereningar, mellanprodukter och foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI932868L (fi) 2'-deoxi-2'2'-difluor(2,6,8-substituerade) purinnukleosider med virus-och cancerhaemmande aktivitet, samt mellanprodukter
FI933065L (fi) Foerfarande foer framstaellning av azabicyklo (2.2.2)oktan-3-iminer och foerfarandet anvaenda mellanprodukter
FI922219A7 (fi) Organokiselfoereningar innehaollande (met)akryloxigrupper, deras framstaellning och anvaendning
FI931459L (fi) Sammansaettningar med 1-klor-2,2,2-trifluoretyldifluor-metyleter
DE59104765D1 (de) Substituierte 5-Alkoxy-1,2,4-triazol-3-(thi)one.
FI944655L (fi) Uudet 2,3-dihydro-2,2,4,6,7-penta-alkyyli-5-bentsofuranolit
FI920400A0 (fi) 2,5-diaryl-1,3,4-oxadiazol-hydroxiester, -hydroxiester,-hydroxisyra och -acetoxiester och deras syntesmetod.
FI923723A7 (fi) 4-(4-(4-(4-hydroksifenyyli)-1-piperatsinyyli)fenyyli)-5-metyyli-3H-1,2,4-triatsoli-3-ooni johdannaisia
FI925111A0 (fi) Substituerade 1,5-pentadioler och foerfarande foer deras framstaellning
FI921456L (fi) Substituerade 2',3'-didesoxi-5-trifluormetyluridiner, foerfaranden foer deras framstaellning och deras anvaendning i laekemedel
FI925441L (fi) 1,4-diamino-2,3-dihydroxibutaner
FI924756A0 (fi) 1,5-benzotiazepinonderivat, deras framstaellning och farmaceutiska anvaendning